Page 2869 - Cote clinical veterinary advisor dogs and cats 4th

1516 Boldface page numbers indicate chapter titles. Page numbers followed by a indicate algorithms; b, boxes; e, electronic content; f, figures; and t, tables.

AZT. See Azidothymidine (AZT) Basal cell tumor, 230–231, 790 Bee stings, 114–115
Azulfidine. See Sulfasalazine Basenji Beer hops toxicosis, 480.e2–480.e3
Behavior modification
enteropathies in, 1221.e1t
VetBooks.ir B familial nephropathy in, 169 for aggression
Fanconi syndrome in, 322–323
Babesia annae, 105
in cats, 40
in dogs, 41–42
inguinal hernia in, 549
Babesia canis, 1172.e2t–1172.e3t
Babesia conradae, 105, 106.e1f
protein-losing enteropathy in, 2.e3, 600
Babesia gibsoni, 105, 106.e1f, 1172.e2t–1172.e3t iris abnormalities in, 563 for barking, 111
for miscellaneous problems, 116
Babesiosis, 105–106, 106.e1f protein-losing nephropathy in, 830.e2 for separation anxiety, 906
hemolytic anemia and, 59 pyruvate kinase deficiency in, 59 Behavior problems. See also Anxiety disorders
Bacillary angiomatosis, 112 renal tubular acidosis in, 879.e2 aggression
Bacillus piliformis, myocarditis and, 675 seasonal estrus in, 759, 817 in cats, 38–40
Back pain, 107–108, 1202 umbilical hernia in, 1003 in dogs, 40–42
Baclofen toxicosis, 108–110 Basophil(s), 1311 barking, excessive, 110–111
Bacterial cholangitis, 455 Basophilia, poor detection by hematology analyzers, 1311 licking, excessive, 589.e2
Bacterial cholecystitis, 455 Basset hound miscellaneous, 115.e2–115.e6
Bacterial culture and sensitivity, 1333 battered pet syndrome. See Abuse prevention of
in abortion, 2–3 epistaxis in, 305 in kittens, 115.e2–115.e3
blood, in infective endocarditis, 295 facial muscle wasting in, 320 in puppies, 115.e4–115.e6
in brucellosis, 138.e4 follicular cysts in, 228.e2 toward veterinary personnel, 38.e2–38.e3
fecal, 1339–1340 glaucoma in, 387 Behavioral assessment, 1063–1064, 1064.e1f
salmonellosis, 899 immunodeficiency syndrome in, 531 Behavioral change, 1202.e2
mycobacterial, 1366–1367 lymphoma in, 609 Belgian sheepdog
of Mycoplasma spp., 1367 mycobacterial culture in, 1366 pannus in, 748
in nodular skin disorders, 695 mycobacterial disease in, 670 pigmentary abnormalities in, 195
Bacterial dermatitis. See Pyoderma myoclonic epilepsy in, 661 Belgian shepherd
Bacterial food poisoning. See Garbage toxicosis neck pain in, 683 epilepsy in, 903
Bacterial infection. See also specific bacteria obesity in, 700 gastric neoplasia in, 379
acute diarrhea and, 257–258 persistent Müllerian duct syndrome in, 780.e3 Belgian Tervuren
of claw, 176–177 platelet dysfunction in, 790.e5 dermatomyositis in, 246.e2
colitis and, 189–190, 190–192, 191.e1f pseudocyesis in, 831 epilepsy in, 903
cystitis and, 232–234 seborrhea in, 214 immune-mediated neutropenia in, 693.e2
fever of unknown origin and, 1223–1225 spinal stenosis in, 933.e2 pannus in, 748
infection sites, isolates from, 1202.e1 temporomandibular joint dysplasia in, 961.e3 Bell’s palsy, 321
myocarditis and, 675 ununited anconeal process in, 288 Belly tap. See Abdominocentesis
pneumonia and, 795–797, 796f ventricular septal defect in, 1036 Benadryl. See Diphenhydramine
bacterial isolates from, 1202.e1 Batten disease, 945.e2–945.e3 Benazepril
smoke inhalation and, 920 Battered pet syndrome, 9 administration and dosage of, 1465
rhinitis and, 890.e2 Bavarian mountain dog, cerebellar cortical degeneration for chronic heart failure, 411
Bacterial overgrowth of small intestine. See Small in, 149.e3 for hypertension, 502
intestinal bacterial overgrowth Baylisascaris infection, 114.e2–114.e3 for nephrotic syndrome, 691
Bacterial overgrowth syndrome, 851 Baytril. See Enrofloxacin for proteinuria of glomerulonephritis, 391
Bacteriuria, 233 Beagle for restrictive cardiomyopathy, 882
subclinical, 110.e2–110.e3 antibiotic-responsive diarrhea in, 260 for tricuspid valve dysplasia, 997
Bactrim. See Trimethoprim-sulfamethoxazole caudal myopathy in, 149.e2 Bence-Jones proteinuria, 1303, 1311
Bactrovet. See Sulfadimethoxine cerebellar cortical degeneration in, 149.e3 Bence-Jones urinary proteins
Bad breath. See Halitosis coagulation factor deficiencies in, 431 in hyperviscosity syndrome, 510
BAER test. See Brainstem auditory evoked response cobalamin deficiency in, 183 multiple myeloma and, 664
(BAER) test corneal dystrophy in, 205 Bengal cat, nasal cutaneous disorders in, 676
Baermann fecal examination, 1310 enteropathies in, 1221.e1t Benign pancreatic nodular hyperplasia, in cats, 739
BAL. See Dimercaprol epilepsy in, 903 Benign prostatic hyperplasia (BPH), 824–826, 825f
Balanitis, 820 eyelid masses in, 318 GnRH vaccine for, 225.e2
Balanoposthitis, 756.e4, 820 familial nephropathy in, 169 Bennies. See Amphetamine toxicosis
Balanopreputial fold remnant, 780.e2 glaucoma in, 387 Benznidazole, 152
Balantidiasis, 830.e6. See also Protozoal enteritides hyperadrenocorticism in, 485 Benzocaine, 1335
Balantidium coli, 830.e6 immunodeficiency syndrome in, 531 Benzodiazepines. See also specific drugs
Balloon valvuloplasty juvenile polyarteritis in, 568.e2 for aggression
for mitral valve dysplasia, 658 myoclonic epilepsy in, 661 in cats, 38.e3, 39
for pulmonic stenosis, 845 neck pain in, 683 in dogs, 38.e3, 41–42
for tetralogy of Fallot, 966 nephrotic syndrome in, 691 for enema, 1099–1100
Banamine. See Flunixin meglumine obesity in, 700 for inappropriate elimination, 534
Band neutrophils, 1357 osteogenesis imperfecta in, 724.e2 for licking, excessive, 589.e2
Bandages pain syndrome in, 942 for obsessive-compulsive disorder, 702
changing of, 910 perianal adenoma in, 31 for phobias, 787
for shearing/degloving wounds, 910 protein-losing nephropathy in, 830.e2 toxicosis caused by, 116–117
Barbering, 589.e2–589.e3 pulmonic stenosis in, 844 Benzoyl peroxide shampoo, for acne, 16
Barbiturates toxicosis, 110.e3–110.e5 pyruvate kinase deficiency in, 59 Benzphetamine. See Amphetamine toxicosis
BARF diet, salmonellosis and, 899–900 steroid-responsive meningitis-arteritis in, 942 Benztropine mesylate, 821.e3
Barium enema, 1062.e1, 1062.e1f stiff dog syndrome in, 661 for priapism, 821.e3
Barium series, upper gastrointestinal, 1172–1173, 1173f stunted growth in, 946 Berenil. See Diminazene
Barking. See also Behavioral assessment third eyelid gland prolapse in, 970 Bernese mountain dog
excessive, 110–111 thyroid neoplasia in, 975 anxiety problems in, 324
Barlow’s disease. See Hypertrophic osteodystrophy (HOD) transitional cell carcinoma in, 991 degenerative myelopathy in, 241
Barotrauma, 1186 vasculitis in, 1031.e4 elbow dysplasia in, 288
Bartonella spp. Beauceron shepherd epilepsy in, 903
B. henselae, 1172.e2t–1172.e4t dermatomyositis in, 246.e2 familial nephropathy in, 169
B. vinsonii var. berkhoffi, 1172.e2t–1172.e3t familial canine dermatomyositis in, 1032 glomerulonephritis in, 390
endocarditis and, 295 footpad disorders in, 350 histiocytic diseases in, 474
myocarditis and, 675–676 nasal cutaneous disorders in, 676 juvenile polyarteritis in, 568.e2
serologic testing for, 1310–1311 Beaver fever. See Giardiasis neck pain in, 683
Bartonellosis, 111–114, 1310 Bedlington terrier nodular skin disorders in, 694
preenrichment culture with PCR, 1310 copper-associated hepatopathy in, 458 osteoarthritis in, 721
BAS. See Brachycephalic airway syndrome familial nephropathy in, 169 osteochondrosis in, 723
Basal cell carcinoma, 230 osteogenesis imperfecta in, 724.e2 protein-losing nephropathy in, 830.e2
Basal cell epithelioma, 230 retinal detachment in, 885 sebaceous adenitis in, 901
www.ExpertConsult.com